{"title":"老年痴呆症患者在疗养院中抗抑郁药物处方的效果——整群随机对照试验。","authors":"Pernille Hølmkjær, Maarten Pieter Rozing, Gritt Overbeck, Volkert Siersma, Anne Holm","doi":"10.1186/s12875-025-02894-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Older nursing home residents with dementia are commonly prescribed antidepressants despite limited evidence of clinical effect and a high risk of side effects. Deprescribing can be challenging and is often not attempted. The aim of the study is to investigate the effect of a multifaceted intervention targeting nursing home general practitioners and their collaboration with the nursing home staff on the reduction of antidepressant medication in older nursing home residents with dementia.</p><p><strong>Method: </strong>The study is a cluster-randomized, non-blinded, controlled trial. General practitioners working as nursing home physicians in the Capital Region of Denmark were recruited between June 1 and October 1, 2021. Eligible participants were individuals with dementia (diagnosed or suspected), ≥ 72 years old, receiving one or more antidepressants, and living in a nursing home with the associated nursing home physician. The complex intervention consisted of three main parts: 1) a training session occurring in the nursing home, 2) a pre-visit reflection tool, and 3) a dialog tool used during a structured home visit at the nursing home. The control group received enhanced care as usual. Primary outcome was the reduction of the total defined daily dose of antidepressants from pre- to post-intervention in the intervention group, compared to the control group. Secondary outcomes included mortality, changes in other psychotropic medication, hospitalization, and symptoms changes.</p><p><strong>Results: </strong>We recruited 21 clusters with 128 eligible participants (62/66 in intervention and control). Four clusters withdrew. Most participants were women, and the median age was 85. They received an average of nine different drugs, and the most commonly prescribed antidepressants were sertraline and mirtazapine. The OR for the reduction of antidepressants in the intervention group versus control was 2.3 (95% CI = 0.84-6.2). Mortality rates were similar between groups.</p><p><strong>Conclusions: </strong>The intervention did not significantly reduce antidepressant use among older nursing home residents with dementia. Further optimization and testing in a larger study are needed.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov ID NCT04985305, registration date: 2021-08-02.</p>","PeriodicalId":72428,"journal":{"name":"BMC primary care","volume":"26 1","pages":"190"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12131616/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effects of deprescribing antidepressants in nursing home residents with dementia-a cluster randomized controlled trial.\",\"authors\":\"Pernille Hølmkjær, Maarten Pieter Rozing, Gritt Overbeck, Volkert Siersma, Anne Holm\",\"doi\":\"10.1186/s12875-025-02894-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Older nursing home residents with dementia are commonly prescribed antidepressants despite limited evidence of clinical effect and a high risk of side effects. Deprescribing can be challenging and is often not attempted. The aim of the study is to investigate the effect of a multifaceted intervention targeting nursing home general practitioners and their collaboration with the nursing home staff on the reduction of antidepressant medication in older nursing home residents with dementia.</p><p><strong>Method: </strong>The study is a cluster-randomized, non-blinded, controlled trial. General practitioners working as nursing home physicians in the Capital Region of Denmark were recruited between June 1 and October 1, 2021. Eligible participants were individuals with dementia (diagnosed or suspected), ≥ 72 years old, receiving one or more antidepressants, and living in a nursing home with the associated nursing home physician. The complex intervention consisted of three main parts: 1) a training session occurring in the nursing home, 2) a pre-visit reflection tool, and 3) a dialog tool used during a structured home visit at the nursing home. The control group received enhanced care as usual. Primary outcome was the reduction of the total defined daily dose of antidepressants from pre- to post-intervention in the intervention group, compared to the control group. Secondary outcomes included mortality, changes in other psychotropic medication, hospitalization, and symptoms changes.</p><p><strong>Results: </strong>We recruited 21 clusters with 128 eligible participants (62/66 in intervention and control). Four clusters withdrew. Most participants were women, and the median age was 85. They received an average of nine different drugs, and the most commonly prescribed antidepressants were sertraline and mirtazapine. The OR for the reduction of antidepressants in the intervention group versus control was 2.3 (95% CI = 0.84-6.2). Mortality rates were similar between groups.</p><p><strong>Conclusions: </strong>The intervention did not significantly reduce antidepressant use among older nursing home residents with dementia. Further optimization and testing in a larger study are needed.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov ID NCT04985305, registration date: 2021-08-02.</p>\",\"PeriodicalId\":72428,\"journal\":{\"name\":\"BMC primary care\",\"volume\":\"26 1\",\"pages\":\"190\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12131616/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC primary care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s12875-025-02894-y\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC primary care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12875-025-02894-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:尽管临床证据有限且副作用风险高,但老年痴呆症养老院居民通常开抗抑郁药。解除处方可能具有挑战性,通常不会尝试。本研究的目的是调查针对养老院全科医生及其与养老院工作人员合作的多方面干预对老年痴呆症养老院居民减少抗抑郁药物治疗的影响。方法:采用整群随机、非盲法对照试验。在2021年6月1日至10月1日期间,在丹麦首都地区担任养老院医生的全科医生被招募。符合条件的参与者是痴呆患者(确诊或疑似),≥72岁,接受一种或多种抗抑郁药物治疗,与相关的养老院医生一起住在养老院。复杂的干预包括三个主要部分:1)在养老院进行的培训课程,2)访问前反思工具,以及3)在养老院进行结构化家访期间使用的对话工具。对照组与往常一样接受强化护理。与对照组相比,主要结局是干预组从干预前到干预后抗抑郁药的总限定日剂量的减少。次要结局包括死亡率、其他精神药物的改变、住院和症状改变。结果:我们招募了21组共128名符合条件的参与者(干预组和对照组分别为62/66)。四组退出。大多数参与者是女性,平均年龄为85岁。他们平均服用九种不同的药物,最常用的抗抑郁药是舍曲林和米氮平。干预组与对照组相比,抗抑郁药物减少的OR为2.3 (95% CI = 0.84-6.2)。两组之间的死亡率相似。结论:干预并没有显著减少老年痴呆养老院居民抗抑郁药的使用。需要在更大的研究中进一步优化和测试。试验注册:ClinicalTrials.gov ID NCT04985305,注册日期:2021-08-02。
Effects of deprescribing antidepressants in nursing home residents with dementia-a cluster randomized controlled trial.
Background: Older nursing home residents with dementia are commonly prescribed antidepressants despite limited evidence of clinical effect and a high risk of side effects. Deprescribing can be challenging and is often not attempted. The aim of the study is to investigate the effect of a multifaceted intervention targeting nursing home general practitioners and their collaboration with the nursing home staff on the reduction of antidepressant medication in older nursing home residents with dementia.
Method: The study is a cluster-randomized, non-blinded, controlled trial. General practitioners working as nursing home physicians in the Capital Region of Denmark were recruited between June 1 and October 1, 2021. Eligible participants were individuals with dementia (diagnosed or suspected), ≥ 72 years old, receiving one or more antidepressants, and living in a nursing home with the associated nursing home physician. The complex intervention consisted of three main parts: 1) a training session occurring in the nursing home, 2) a pre-visit reflection tool, and 3) a dialog tool used during a structured home visit at the nursing home. The control group received enhanced care as usual. Primary outcome was the reduction of the total defined daily dose of antidepressants from pre- to post-intervention in the intervention group, compared to the control group. Secondary outcomes included mortality, changes in other psychotropic medication, hospitalization, and symptoms changes.
Results: We recruited 21 clusters with 128 eligible participants (62/66 in intervention and control). Four clusters withdrew. Most participants were women, and the median age was 85. They received an average of nine different drugs, and the most commonly prescribed antidepressants were sertraline and mirtazapine. The OR for the reduction of antidepressants in the intervention group versus control was 2.3 (95% CI = 0.84-6.2). Mortality rates were similar between groups.
Conclusions: The intervention did not significantly reduce antidepressant use among older nursing home residents with dementia. Further optimization and testing in a larger study are needed.
Trial registration: ClinicalTrials.gov ID NCT04985305, registration date: 2021-08-02.